Articles on the use of intravitreal triamcinolone, intravenous immunoglobulin, cyclosporine alone, cyclosporine plus mycophenolate mofetil, methotrexate, infliximab, and daclizumab can be found in the literature on the treatment ofBCR with varying success and no mention of response differences between the genders [5, 7, 21-23, 71, 73,74].